Idiopathic hypersomnia (IH) is a chronic, neurologic disorder with a primary symptom of excessive daytime sleepiness
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - September 2025 Issue
August 2025 Legislative Briefing
Share your research in a whole new way with AMCP ePosters powered by Digital Health Outcomes (DHO). Turn your poster into an interactive digital experience that goes beyond the conference floor—complete with live data, clickable features, and year-round visibility on the AMCP eModel Hub.
On August 20, 2025, the U.S. Department of Health and Human Services (HHS) issued updates (the Interim Final Rule) which amends the final rule titled “Administrative Simplification: Modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA) National Council for Prescription Drug Programs (NCPDP) Retail Pharmacy Standards; and Modification of the Medicaid Pharmacy Subrogation Standard,” (the December 2024 Final Rule).
In June, the Academy of Managed Care Pharmacy (AMCP) convened leading experts from across health care disciplines for a two-day Precision Medicine Partnership Forum. The forum aimed to advance equitable and timely access to precision medicine, particularly in oncology.
Meet AMCP Diplomat Shobhna Butler, MBA, PharmD, RPh
Just after midnight on the morning of Aug. 7, President Trump’s sweeping “reciprocal” tariffs took effect on dozens of international trading partners, marking another dramatic escalation of the administration’s “America First” trading policy.
In both of his administrations, President Trump promoted most-favored nation (MFN) pricing as a way to bring down drug costs in the United States. On July 31, 2025, President Trump sent letters to 17 pharmaceutical manufacturers demanding that they implement MFN prices or face the consequences.
Join us for One, Big Beautiful Webinar, a timely and essential session exploring the sweeping implications of H.R. 1 on the managed care landscape.
